ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 177 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $329,000 | -34.2% | 15,075 | -9.9% | 0.01% | -36.4% |
| Q3 2021 | $500,000 | -54.8% | 16,731 | -32.9% | 0.01% | -54.2% |
| Q2 2021 | $1,105,000 | +3.6% | 24,948 | +3.7% | 0.02% | +4.3% |
| Q1 2021 | $1,067,000 | +69.1% | 24,054 | +109.2% | 0.02% | +91.7% |
| Q4 2020 | $631,000 | +37.2% | 11,500 | -42.9% | 0.01% | 0.0% |
| Q3 2020 | $460,000 | -8.5% | 20,127 | -16.2% | 0.01% | -14.3% |
| Q2 2020 | $503,000 | +49.3% | 24,024 | -0.6% | 0.01% | +7.7% |
| Q1 2020 | $337,000 | -25.9% | 24,171 | +20.9% | 0.01% | +85.7% |
| Q4 2019 | $455,000 | +95.3% | 20,000 | 0.0% | 0.01% | +40.0% |
| Q3 2019 | $233,000 | -8.6% | 20,000 | +17.6% | 0.01% | -28.6% |
| Q2 2019 | $255,000 | +16.4% | 17,000 | +36.0% | 0.01% | +40.0% |
| Q1 2019 | $219,000 | +5.8% | 12,500 | -10.7% | 0.01% | -44.4% |
| Q4 2018 | $207,000 | – | 14,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 16,037,486 | $280,250,000 | 19.13% |
| TANG CAPITAL MANAGEMENT LLC | 2,965,485 | $52,015,000 | 9.58% |
| Boxer Capital, LLC | 1,466,051 | $25,715,000 | 2.97% |
| Ghost Tree Capital, LLC | 600,000 | $10,524,000 | 2.75% |
| BRIDGER MANAGEMENT, LLC | 1,529,032 | $26,819,000 | 2.12% |
| Cormorant Asset Management, LP | 1,700,000 | $29,818,000 | 2.02% |
| EcoR1 Capital, LLC | 450,000 | $7,893,000 | 0.73% |
| UNIVERSITY OF NOTRE DAME DU LAC | 171,015 | $3,000,000 | 0.67% |
| Virtus ETF Advisers LLC | 17,799 | $312,000 | 0.66% |
| SPHERA FUNDS MANAGEMENT LTD. | 290,001 | $5,087,000 | 0.46% |